Evidence map›Paper›PMID 41667747›Full record

ArticleScientific reports2026

Genomic and in vitro characterization of two lytic bacteriophages infecting multidrug-resistant Erwinia sp. strain AnSW2-5.

Kiwoon Baek, Jaeduk Goh, Ahoung Choi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kiwoon BaekBiological Resources Research Department, Nakdonggang National Institute of Biological Resources (NNIBR), Sangju, 37242, Republic of Korea.
Jaeduk GohBiological Resources Research Department, Nakdonggang National Institute of Biological Resources (NNIBR), Sangju, 37242, Republic of Korea.
Ahoung ChoiBiological Resources Research Department, Nakdonggang National Institute of Biological Resources (NNIBR), Sangju, 37242, Republic of Korea. aychoi@nnibr.re.kr.

Funding

Korea Environmental Industry and Technology Institute RS-2021-KE001787Nakdonggang National Institute of Biological Resources NNIBR20263102
6 · The paper itself

Abstract

Multidrug-resistant (MDR) Erwinia pathogens present a critical threat to global crop health and agricultural sustainability. In this study, we characterized two novel lytic bacteriophages, AnSW2-5-P-A (family Autographiviridae) and AnSW2-5-P-K (class Caudoviricetes), targeting the MDR Erwinia sp. strain AnSW2-5. Comparative genomics and TEM analysis revealed distinct virion architectures and confirmed the absence of lysogeny-associated genes, ensuring their safety as biocontrol agents. One-step growth assays demonstrated that P-A has a shorter latent period (~ 20 min), while P-K exhibits a significantly larger burst size (~ 110 PFU/cell). In co-culture assays, the dual-phage cocktail demonstrated a profound synergistic effect, achieving > 80% bacterial reduction (p < 0.05) and maintaining sustained suppression of the host for 72 h. Notably, the cocktail effectively prevented the emergence of resistant mutants, reducing the frequency of resistance (FoR) to below the limit of detection (< 10⁻⁸). These findings highlight the potential of using genetically diverse phage pairs with complementary lytic activities as a robust, resistance-suppressive biocontrol strategy against MDR phytopathogens.

Indexed as

BacteriophagesDrug Resistance, Multiple, BacterialErwiniaGenome, ViralGenomicsAutographiviridaeBacteriophageBiocontrolCaudoviricetesComparative genomicsErwiniaMultidrug-resistance (MDR)Synergistic effect

Identifiers

PMID41667747
PMCPMC12963601

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.